Chemical Formula | C41H50F2N2O5Si2 |
Molecular Weight | 737.02 g/mol |
Appearance | Solid (usually) |
Physical State At Room Temp | Solid |
Solubility In Water | Low (organic compound with non - polar groups) |
Solubility In Organic Solvents | Soluble in common organic solvents like dichloromethane, chloroform |
Chemical Name | (4S)-3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino][4-[(trimethylsilyl)oxy]phenyl]methyl]-1-oxo-5-[(trimethylsilyl)oxy]pentyl]-4-phenyl-2-oxazolidinone |
Molecular Formula | C43H52F2N2O5Si2 |
Molecular Weight | 773.06 g/mol |
Physical State | Solid (predicted) |
Solubility | Solubility in common organic solvents like dichloromethane, chloroform (predicted based on structure) |
Logp | Predicted to be relatively lipophilic due to large hydrophobic groups |
Chemical Name | (4S)-3-[(2R,5S)-5-(4-Fluorophenyl)-2-[(S)-[(4-fluorophenyl)amino][4-[(trimethylsilyl)oxy]phenyl]methyl]-1-oxo-5-[(trimethylsilyl)oxy]pentyl]-4-phenyl-2-oxazolidinone |
Molecular Formula | C43H50F2N2O5Si2 |
Molecular Weight | 761.04 g/mol |
Physical State | Solid (presumably, based on typical organic compounds of this complexity) |
Solubility | Expected to be sparingly soluble in water; solubility in organic solvents like dichloromethane, chloroform, etc. needs experimental determination |
Functional Groups | Oxazolidinone, phenyl, fluorophenyl, trimethylsilyloxy, amide (implicit in the structure) |
Chemical Formula | C40H51F2N2O5Si2 |
Molecular Weight | 723.02 g/mol |
Physical State | Solid (predicted) |
Solubility | Soluble in organic solvents like dichloromethane, chloroform (predicted) |
Logp | High (due to large non - polar groups, predicted) |
What is the chemical structure of (4S) -3- [ (2R, 5S) -5- (4-fluorophenyl) -2- [ (S) - [ (4-fluorophenyl) amino] [4- [ (trimethylsilyl) oxy] phenyl] methyl] -1-oxo-5- [ (trimethylsilyl) oxy] pentyl] -4-phenyl-2-oxazolidinone?
Looking at the naming of this compound (4S) -3- [ (2R, 5S) -5- (4-fluorophenyl) -2 - [ (S) - [ (4-fluorophenyl) oxy] [4- [ (trimethylsilyl) oxy] phenyl] ethyl] -1 -oxo-5- [ (trimethylsilyl) oxy] pentyl] -4 -phenyl-2 -oxazolidone, To know its chemical structure, let me analyze it in detail.
This nomenclature follows the rules of organic chemistry, and is composed of fragments to describe the exact structure of the compound. " (4S) ", " (2R, 5S) " and " (S) ", etc., which indicate the three-dimensional configuration of specific atoms in a molecule, which is related to the arrangement of atoms in space.
"3- [ (2R, 5S) -5- (4-fluorophenyl) -2 - [ (S) - [ (4-fluorophenyl) oxy] [4- [ (trimethylsilyl) oxy] phenyl] ethyl]", this part indicates that at position 3 of the main chain, a side chain with a specific stereo configuration is connected, and the side chain contains 4-fluorophenyl at position 5, and ethyl at position 2 with complex substitution, and ethyl has different substituted phenyl and oxygen groups.
"1-oxo-5- [ (trimethylsilyl) oxy] pentyl", it can be seen that the aerobic group at position 1 of the main chain, and the pentyl group with trimethylsiloxy at position 5 are connected. "4-Phenyl-2-oxazolidone", indicating that the main chain is also connected to the phenyl group at position 4, and the structural unit that forms 2-oxazolidone.
By combining the parts of this naming, the chemical structure of the compound can be gradually constructed. Each group is connected to the three-dimensional configuration according to the position indicated by the naming, so as to present the exact appearance of this complex compound.
What are the main uses of (4S) -3- [ (2R, 5S) -5- (4-fluorophenyl) -2- [ (S) - [ (4-fluorophenyl) amino] [4- [ (trimethylsilyl) oxy] phenyl] methyl] -1-oxo-5- [ (trimethylsilyl) oxy] pentyl] -4-phenyl-2-oxazolidinone?
(4S) - 3 - [ (2R, 5S) - 5 - (4 - chlorophenyl) - 2 - [ (S) - [ (4 - chlorophenyl) oxy] [4 - [ (trimethylsilyl) oxy] phenyl] ethyl] - 1 - oxo - 5 - [ (trimethylsilyl) oxy] pentyl] - 4 - phenyl - 2 - oxazolidinone This substance has a wide range of uses. In the field of medicine, due to its unique chemical structure and chiral characteristics, it can be used as a key intermediate in the synthesis of specific chiral drugs, which can accurately construct pharmaceutical active ingredients, which is of great significance for improving drug efficacy and reducing side effects. In the field of organic synthetic chemistry, as a multi-functional synthetic block, with its multiple reaction check points and three-dimensional chemical properties, it can participate in the construction of many complex organic molecules, enabling chemists to efficiently synthesize organic compounds with specific structures and functions, laying the foundation for the development of new materials and the development of organic synthesis methodologies. In the field of asymmetric catalysis, due to the existence of chiral centers, they can be used as chiral ligands or catalysts to induce asymmetric reactions, improve reaction enantioselectivity, and promote the formation of products in a specific chiral configuration. They provide an effective way to obtain high-purity chiral compounds and play a key role in the synthesis of fine chemicals.
What are the synthesis methods of (4S) -3- [ (2R, 5S) -5- (4-fluorophenyl) -2- [ (S) - [ (4-fluorophenyl) amino] [4- [ (trimethylsilyl) oxy] phenyl] methyl] -1-oxo-5- [ (trimethylsilyl) oxy] pentyl] -4-phenyl-2-oxazolidinone?
To prepare (4S) - 3 - [ (2R, 5S) - 5 - (4 - fluorophenyl) - 2 - [ (S) - [ (4 - fluorophenyl) oxy] [4 - [ (trimethylsilyl) oxy] phenyl] ethyl] - 1 - oxo - 5 - [ (trimethylsilyl) oxy] pentyl] - 4 - phenyl - 2 - oxazolidinone, the following methods can be used.
First, start with raw materials containing specific chiral structures, and build the target structure with ingenious reaction sequences. If a compound with a suitable chiral center is selected, it will gradually reach the target molecule through a series of reactions such as nucleophilic substitution, oxidation, and condensation. During nucleophilic substitution, the check point and stereochemistry of the reaction are precisely controlled to ensure the stability of the chiral center configuration; the oxidation step requires the selection of an appropriate oxidant to make the degree of oxidation moderate; in the condensation reaction, the reaction conditions are optimized to improve the reaction yield and selectivity.
Second, the catalytic asymmetric synthesis strategy is adopted. With the help of high-efficiency chiral catalysts, the asymmetric transformation of key steps is realized. Chiral catalysts are carefully screened to consider their affinity for substrates, catalytic activity and stereoselectivity. For example, chiral metal complex catalysts can induce the formation of products of specific configurations in allylation, cyclization and other reactions. And the reaction conditions are mild, environmentally friendly, and in line with the concept of green chemistry.
Third, use the protective group strategy. In view of the many sensitive functional groups in the molecule, it is necessary to introduce and remove the protective group reasonably. For example, easy reactive groups such as hydroxyl groups are protected by protective groups such as trimethylsilyl groups. After the specific reaction is completed, the protective group is removed under mild conditions to restore the activity of the functional group and ensure the smooth progress of the synthesis route. In this way, through multi-method coordination, it is expected to efficiently synthesize this complex organic compound.
How competitive is (4S) -3- [ (2R, 5S) -5- (4-fluorophenyl) -2- [ (S) - [ (4-fluorophenyl) amino] [4- [ (trimethylsilyl) oxy] phenyl] methyl] -1-oxo-5- [ (trimethylsilyl) oxy] pentyl] -4-phenyl-2-oxazolidinone in the market?
(4S) - 3 - [ (2R, 5S) - 5 - (4 - chlorophenyl) - 2 - [ (S) - [ (4 - chlorophenyl) amino] [4 - [ (trimethylsilyl) oxy] phenyl] methyl] - 1 - oxo - 5 - [ (trimethylsilyl) oxy] hexyl] - 4 - phenyl - 2 - oxazolidinone How competitive is this product in the market? And listen to me in the ancient style of "Tiangong Kaiwu".
Guanfu (4S) - 3- [ (2R, 5S) - 5- (4-chlorophenyl) - 2 - [ (S) - [ (4-chlorophenyl) amino] [4- [ (trimethylsilyl) oxy] phenyl] methyl] - 1 -oxo-5- [ (trimethylsilyl) oxy] hexyl] - 4 -phenyl-2 -oxazolidinone, its structure is exquisite and contains the wonders of creation. In today's market, the judgment of competitiveness is related to the number end.
First, it depends on its function. This compound may have unique properties in the fields of medicine and chemical industry. If it is used in medicine, it can be used as a special drug to treat intractable diseases, and it will surely attract the attention of doctors and patients. The needs of the market are wide and the competitiveness is self-strengthening. If it is used in chemical industry, it is a key material for synthesis and helps to produce kickknacks, it can also occupy a place in the industry.
Second, look at its preparation. The difficulty of preparation and the high cost are all important factors. If the preparation method is simple, the raw materials are easy to find and inexpensive, and it can be produced in large quantities and supplied to the market without fear, it can win by quantity and price. On the contrary, if the preparation is cumbersome, the cost is high, and even if there is good ability, it is difficult to travel in the market.
Third, look at competing products. In the market, similar products may already be numerous. If this (4S) -3- [ (2R, 5S) -5- (4-chlorophenyl) -2- [ (S) - [ (4-chlorophenyl) amino] [4- [ (trimethylsilyl) oxy] phenyl] methyl] -1 -oxo-5- [ (trimethylsilyl) oxy] hexyl] -4-phenyl-2-oxazolidinone has unique advantages, excellent performance, or close price, it can stand out and be competitive.
Fourth, on the needs of the times. The world is changing, and the needs of the market are also changing. If this compound coincides with the times and is born in response to new needs during the period of pharmaceutical innovation and chemical transformation, its competitiveness will skyrocket.
In general, (4S) -3- [ (2R, 5S) -5- (4-chlorophenyl) -2- [ (S) - [ (4-chlorophenyl) amino] [4- [ (trimethylsilyl) oxy] phenyl] methyl] -1 -oxo-5- [ (trimethylsilyl) oxy] hexyl] - 4 -phenyl-2 -oxazolidinone The strength of market competitiveness depends on various factors such as function, preparation, competition and current situation, and can only be used if it is well observed and used It rose to prominence in the market competition and made long-term profits.
(4S) -3- [ (2R, 5S) -5- (4-fluorophenyl) -2- [ (S) - [ (4-fluorophenyl) amino] [4- [ (trimethylsilyl) oxy] phenyl] methyl] -1-oxo-5- [ (trimethylsilyl) oxy] pentyl] -4-phenyl-2-oxazolidinone What are the precautions during storage and transportation?
(4S) - 3 - [ (2R, 5S) - 5 - (4 - fluorophenyl) - 2 - [ (S) - [ (4 - fluorophenyl) amino] [4 - [ (trimethylsilyl) oxy] phenyl] methyl] - 1 - oxo - 5 - [ (trimethylsilyl) oxy] pentyl] - 4 - phenyl - 2 - oxazolidinone This drug should pay attention to the following things during storage and transportation:
First, temperature and humidity control. This drug is mostly sensitive to temperature and humidity. High temperature may cause the drug to deteriorate, and the efficacy of the drug will be damaged; if the humidity is too high, it may cause the drug to deliquescent and mildew. Therefore, it is necessary to store it in a suitable temperature and humidity environment, such as a specific temperature range, and pay attention to moisture-proof, or use a desiccant to keep it dry.
Second, prevent direct light exposure. Many drugs will have photochemical reactions after being exposed to light, resulting in structural changes and reduced efficacy. The same is true for this drug. During storage and transportation, avoid direct light, and use light-shielding packaging materials, such as brown bottles, light-shielding bags, etc.
Third, avoid vibration and collision. Violent vibration and collision, or damage the drug dosage form, such as breaking the tablet or breaking the capsule. For medicines with special dosage form requirements, it is necessary to handle them with care to ensure smooth transportation, and fill the packaging with buffer materials to reduce the impact of vibration.
Fourth, classified storage. If it is transported and stored with other medicines, it should be classified according to the nature of the medicine to avoid mutual reactions. Especially this medicine contains a special chemical structure, and more attention should be paid to avoid mixing with medicines that may react.
Fifth, follow regulations. Storage and transportation must be strictly in accordance with drug management regulations to ensure compliance in all links. If the transportation must have corresponding qualifications, the storage facilities must meet the prescribed standards.